Japanese pharmaceutical company headquartered in Doshomachi, Chuo ward, Osaka, founded in 1878 and listed in Tokyo. Researches, develops, makes and sells prescription medicines with strengths in infectious disease, including the antibiotic cefiderocol and the antiviral ensitrelvir for COVID-19, in HIV medicines developed with ViiV Healthcare in which it holds a stake, and in pain and central nervous system products, and it runs research centres and plants in Japan together with subsidiaries in the United States, Europe and China and the Qpex antibiotic business it bought in 2023.
Aucun commentaire disponible.
Laissez votre note & commentaire